A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Clinical trial NCT06176963 · COMPLETED

Trial details

NCT number: NCT06176963
Sponsor: Samsung Bioepis Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Macular Edema Retinal Vein Occlusion

Start date: 2023-11-21
Primary completion: 2023-11-30
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.